Pronađeno: 1-6 / 6 radova

Autori: Camp Heidi S

>> Filter: Samo Article i Review

>> Sve godine

Naslov Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 260 Weeks from the Select-Monotherapy Study (Meeting Abstract)
Autori Smolen Josef S Emery Paul Rigby William Tanaka Yoshiya Ignacio Vargas Juan Damjanov Nemanja S Jain Manish Kato K Carter K Khan N Camp Heidi S Cohen Stanley B 
Info ANNALS OF THE RHEUMATIC DISEASES, (2023), vol. 82 br. , Suppl. 1, str. 723-724
Projekat AbbVie
Ispravka Web of Science   Članak   Elečas   Rang časopisa  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks (Meeting Abstract)
Autori Smolen Josef S Emery Paul Rigby William Tanaka Yoshiya Ignacio Vargas Juan Damjanov Nemanja S Jain Manish Sui Yunxia Enejosa Jeffrey Pangan Aileen L Camp Heidi S Cohen Stanley B 
Info ARTHRITIS & RHEUMATOLOGY, (2019), vol. 71 br. , Suppl. 10, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov The Association Between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib (Meeting Abstract)
Autori Strand Vibeke Damjanov Nemanja S Scoville Craig Tundia Namita Camp Heidi S Chen Kun Suboticki Jessica L Van Vollenhoven Ronald 
Info JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, (2019), vol. 25 br. , Suppl. 3, str. S54-S54
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy Study (Meeting Abstract)
Autori Smolen Josef S Emery Paul Rigby William Tanaka Yoshiya Ignacio Vargas Juan Damjanov Nemanja S Jain Manish Tanaka Yoshiya Enejosa Jeffrey Pangan Aileen L Camp Heidi S Cohen Stanley B 
Info ANNALS OF THE RHEUMATIC DISEASES, (2019), vol. 78 br. , Suppl. 2, str. 371-372
Projekat AbbVie, Inc
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study (Article)
Autori Smolen Josef S Pangan Aileen L Emery Paul Rigby William Tanaka Yoshiya Vargas Juan Ignacio Zhang Ying Damjanov Nemanja S Friedman Alan Othman Ahmed A Camp Heidi S Cohen Stanley B 
Info LANCET, (2019), vol. 393 br. 10188, str. 2303-2311
Projekat AbbVie Inc, USA
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov The Association between Patient Reported Outcomes and Clinical Measures Among Rheumatoid Arthritis Patients: Analyses Using Phase 3 Clinical Trials of Upadacitinib (Meeting Abstract)
Autori Strand Vibeke Damjanov Nemanja S Scoville Craig Tundia Namita Camp Heidi S Chen Kun Suboticki Jessica L Van Vollenhoven Ronald 
Info ARTHRITIS & RHEUMATOLOGY, (2018), vol. 70 br. , Suppl. 9, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX